Evidence map›Paper›PMID 29986647›Full record

ArticleBMC genomics2018

Novel long-range regulatory mechanisms controlling PKD2 gene expression.

Stéphanie Moisan, Stéphanie Levon, Emilie Cornec-Le Gall, Yannick Le Meur, Marie-Pierre Audrézet, Josée Dostie, Claude Férec

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Stéphanie MoisanInstitut National de la Santé et de la Recherche Médicale (INSERM), U1078, Brest, Bretagne, France. moisan.stephanie@hotmail.fr.ORCID http://orcid.org/0000-0002-9745-1152
Stéphanie LevonInstitut National de la Santé et de la Recherche Médicale (INSERM), U1078, Brest, Bretagne, France.
Emilie Cornec-Le GallInstitut National de la Santé et de la Recherche Médicale (INSERM), U1078, Brest, Bretagne, France.
Yannick Le MeurService de néphrologie, Centre Hospitalier Régional Universitaire (CHRU), Brest, Bretagne, France.
Marie-Pierre AudrézetInstitut National de la Santé et de la Recherche Médicale (INSERM), U1078, Brest, Bretagne, France.
Josée DostieDepartment of Biochemistry and Goodman Cancer Research Center, McGill University, Montréal, Québec, Canada.
Claude FérecInstitut National de la Santé et de la Recherche Médicale (INSERM), U1078, Brest, Bretagne, France. claude.ferec@univ-brest.fr.
Inserm · FRCentre Hospitalier Régional Universitaire de Brest · FRMcGill University · CA

Funding

Canadian Institutes of Health Research (CA) CIHR MOP-142451
6 · The paper itself

Abstract

backgroundCis-regulatory elements control gene expression over large distances through the formation of chromatin loops, which allow contact between enhancers and gene promoters. Alterations in cis-acting regulatory systems could be linked to human genetic diseases. Here, we analyse the spatial organization of a large region spanning the polycystic kidney disease 2 (PKD2) gene, one of the genes responsible of autosomal dominant polycystic kidney disease (ADPKD).

resultsBy using chromosome conformation capture carbon copy (5C) technology in primary human renal cyst epithelial cells, we identify novel contacts of the PKD2 promoter with chromatin regions, which display characteristics of regulatory elements. In parallel, by using functional analysis with a reporter assay, we demonstrate that three DNAse I hypersensitive sites regions are involved in the regulation of PKD2 gene expression.

conclusionsFinally, through alignment of CCCTC-binding factor (CTCF) sites, we suggest that these novel enhancer elements are brought to the PKD2 promoter by chromatin looping via the recruitment of CTCF.

Indexed as

A549 CellsChromatinDeoxyribonuclease IEnhancer Elements, GeneticEpithelial CellsGene ExpressionHumansKidneyPolycystic Kidney, Autosomal DominantPromoter Regions, GeneticTRPP Cation ChannelsChromatinDeoxyribonuclease ITRPP Cation ChannelsADPKD, PKD2, Chromatin organization, Enhancer, Gene expression, Transcription regulation

Identifiers

PMID29986647
PMCPMC6038307
OpenAlexW2882552267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.